It Is Possible to Classify Non-erosive Reflux Disease (NERD) Patients into Endoscopically Normal Groups and Minimal Change Groups by Subjective Symptoms and Responsiveness to Rabeprazole—A Report from a Study with Japanese Patients

被引：0
作者：
Motoyasu Kusano
Naohito Shirai
Kanako Yamaguchi
Michio Hongo
Tsutomu Chiba
Yoshikazu Kinoshita
机构：
[1] Gunma University Hospital,Department of Endoscopy and Endoscopic Surgery
[2] Enshu Hospital,Department of Gastroenterology
[3] Saga Medical School,Department of Internal Medicine
[4] Tohoku University Hospital,Departments of Comprehensive Medicine and Psychosomatic Medicine
[5] Kyoto University Graduate School of Medicine,Department of Gastroenterology and Hepatology
[6] Shimane University School of Medicine,Department of Gastroenterology and Hepatology
来源：
Digestive Diseases and Sciences | 2008年 / 53卷
关键词：
NERD; Symptom; Rabeprazole; Minimal change; Questionnaire;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The hypothesis that non-erosive reflux disease (NERD) patients comprise various subgroups is gaining popularity. This study was conducted to investigate the possibility of categorizing NERD patients according to symptom types and response to acid-suppressive drug rabeprazole (RPZ) 10 mg/day. NERD patients were classified as grade N (endoscopically normal), M (minimal change), or erosive GERD, and answered a 51-item, yes-or-no questionnaire pre and post-treatment. Compared to erosive GERD, clear differences existed in pretreatment prevalence of symptoms and responsiveness to RPZ in grades N and M; the results suggested stomachaches (especially at night) were significant symptoms in grade N and dysmotility-like symptoms like bloated stomach were significant in grade M while gastroesophageal reflux symptoms were significant in erosive GERD. Clinical significance of classifying NERD was indicated from different symptoms and responsiveness to PPI.
引用
收藏
页码：3082 / 3094
页数：12
相关论文
共 184 条
[11]  
Vakil N(2003)Diagnosis of symptomatic gastroesophageal reflux disease Am J Gastroenterol 98 S15-26
[12]  
van Zanten SV(2004)Endoscopic findings of GERD Nippon Rinsho 62 1459-99
[13]  
Kahrilas P(2005)Minimal change oesophagitis: a disease with characteristic differences to erosive oesophagitis Aliment Pharmacol Ther 21 19-1339
[14]  
Dent J(2006)Minimal changes in reflux esophagitis: red ones and white ones J Gastroenterol 41 95-3098
[15]  
Jones R(2002)Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial Aliment Pharmacol Ther 97 1332-1398
[16]  
Chiba N(2005)Rabeprazole vs. esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia World J Gastroenterol 11 3091-454
[17]  
De Gara CJ(2003)Symptom relief in patients with reflux esophagitis: comparative study of omeprazole, lansoprazole, and rabeprazole J Gastroenterol Hepatol 18 1392-485
[18]  
Wilkinson JM(2002)Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis Aliment Pharmacol Ther 16 445-758
[19]  
Hunt RH(2002)A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease Aliment Pharmacol Ther 16 479-1456
[20]  
van Pixteren B(2005)Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan Am J Gastroenterol 100 754-G284
12345678910